Skip to main content

Personal Care Ingredients Market Size, Share & Trends Analysis Report 2019-2029


The introduction and proliferation of bio-based ingredients in several industries, such as food and beverage, pharmaceuticals, and cosmetics, has been transforming the manufacturing landscape since 2000. Growing consumer inclination toward the adoption of bio-based products due to rising health and environmental concerns is driving the demand for bio-based ingredients in the cosmetics and personal care products. Besides, awareness among consumers regarding the harmful effects of synthetic ingredients chemicals has grown rapidly over the past years. In addition, the availability of green raw materials has also urged large cosmetic firms to develop bio-based cosmetic products.

However, limited availability of raw material, due to erratic weather conditions and stringent environmental regulations, can pose substantial hurdles in the production of bio-based ingredients. Thus, leading companies have been focusing on developing new and sustainable ways of producing the ingredients to meet consumer expectations. Presently, biotechnologically produced ingredients for pharmaceuticals have a more substantial market share as compared to the cosmetics market. Thus, early adoption of the product, government initiatives, increasing production capacities of bio-based chemicals, coupled with the presence of potential industry participants, are likely to drive the market growth during the forecast period.

The cosmetics and personal care sector is a key industry that contributes considerably to the world’s gross domestic product (GDP). Cosmetics can be chemically synthesized or naturally derived. With growing awareness of the potential side-effects of synthetic ingredients in cosmetics, the demand for cleaner and greener products increased rapidly in the past few years. The consumer inclination toward healthier lifestyles and products which have a minimal effect on the environment are among the key drivers of the growth of bio-based ingredients for cosmetics and personal care. In addition, increased per capita income, changing consumer lifestyles in the developing countries, along with rising awareness about beautification are also contributing to the development of the overall cosmetics industry, which in turn benefits the bio-based cosmetic ingredients manufacturers.


The consumer demand for natural products, along with bio-based products derived from oils and fats, has resulted in a rapid growth of the bio-based cosmetics and personal care ingredients market. The primary factor for the increasing adoption of bio-based ingredients for cosmetic products is the harmful effects of chemical products, therefore leading to consumers showcasing an inclination toward products that contain bio-based ingredients. As a result, cosmetics companies are consequently substituting synthetic chemicals with bio-based ingredients. In 2013, L’Oreal, one of the largest cosmetics companies launched Sharing Beauty With All to improve sustainability from sourcing and manufacturing to packaging, hence lowering its environmental footprints.

Five major cosmetics categories including foundation, face cream, lipstick, mascara, and blush/bronzer contain at least one high risk commodity which has an ill-effect on health. For example, vanilla is a popular ingredient in lipstick, but it contains high risk of cancer and allergic reactions. About XX% of ingredients used in ordinary cosmetic products come from agricultural or mined commodities. Various ingredients are derived from mines, including tin, zinc, and copper, all of which contains high chemical risk.

Comments

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...

Neoantigens Vaccines Can Bridge the Treatment Gap by Training the Immune System to Recognize Tumor Cells

As per BIS Research analysis, the neoantigen cancer vaccine market is projected to reach $1826.1 million by 2030 from $227.1 million in 2023, at a CAGR of 34.69%. Growth in this market is expected to be driven by the ever-rising patient pool of different cancers and significant investment in research for development for cancer neoantigen vaccines to fill in the current treatment gaps. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of therapy (personalized cancer vaccines), manufacturing complications, and lack of therapeutic biomarkers and assays. The market is still at the nascent phase with more than two-thirds of the neovaccines in the early stages of development. However, few neovaccines companies such as OSE Immunotherapeutics, Immunovative Therapeutics, Medigene, and Roche have positioned themselves to launch their neovaccines in the market within the upcoming years. That being said, the neovacc...